What's the Latest? Behind the Design of a 24/7 Post-Overdose and MOUD Initiation Center
Join us for What’s the Latest? – a quarterly webinar series addressing innovative approaches related to medications for opioid use disorder (MOUD).
This session will highlight the Opioid Recovery Care Access (ORCA) Center—a 24/7, judgment-free space for recovery after overdose, MOUD initiation, and stabilization.
Opened in September 2025, ORCA quickly gained traction. We’ll cover its design process, partnerships with the Downtown Emergency Service Center (DESC), Seattle Fire, local healthcare providers, UW researchers, the Lived Expertise Advisory Board, and local government, and introduce utilization and outcome metrics.
Speakers:
Daniel Malone, Executive Director, DESC
Susan McLaughlin, PhD, Director, Behavioral Health and Recovery Division
Michael R. Sayre, MD, Medical Director, Seattle Fire Department; Professor of Emergency Medicine, University of Washington
Who should attend: This series is for anyone in Washington State involved in SUD treatment or interested in developing similar programs. While…
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/glAl4YQ3Tmab4FFmrZ8NbQ#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Wednesday, January 7, 2026, 12:00 PM – 1:00 PM.
Webinar - Register at: https://washington.zoom.us/meeting/register/glAl4YQ3Tmab4FFmrZ8NbQ#/registration.
ADAI Lunch & Learn: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder
Presenter:
Kevin Coffey, PhD. Research Assistant Professor, UW Psychiatry & Behavioral Sciences
Kevin Coffey is a Research Assistant Professor in Psychiatry and Behavioral Sciences at the University of Washington and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making. Dr. Coffey’s current focus is on studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, his lab utilizes cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, MiniScopes, etc.) along with a newly developed oral fentanyl self-administration model for rats and mice. His recently funded ADAI pilot grant aims to explore the use of the GLP-1R agonist dulaglutide for treatment of fentanyl use disorder in his rodent models.
Event interval: Single day event. Online Meeting Link: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration. Accessibility Contact: Meg Brunner, meganw@uw.edu. Event Types: Lectures/Seminars.
Thursday, January 29, 2026, 12:00 PM – 1:00 PM.
Webinar - register at: https://washington.zoom.us/meeting/register/R2E_CapZRbybpRYqz3fewA#/registration.
For more info visit washington.zoom.us.